Patient preferences for medicine administration for acute agitation: results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries

References

• Alderfer, B. S., & Allen, M. H. (2003). Treatment of agitation in bipolar disorder across the life cycle. The Journal of Clinical Psychiatry, 64, 3–9.
   PubMed Web of Science ®Google Scholar
• Allen, M. H., Feifel, D., Lesem, M. D., Zimbroff, D. L., Ross, R., Munzar, P., … Cassella, J. V. (2011). Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry, 72, 1313–1321.10.4088/JCP.10m06011yel
   PubMed Web of Science ®Google Scholar
• Asmal, L., Flegar, S. J., Wang, J., Rummel-Kluge, C., Komossa, K., & Leucht, S. (1996). Quetiapine versus other atypical antipsychotics for schizophrenia. In Cochrane database of systematic reviews. Hoboken, NJ: Wiley.
   Google Scholar
• Battaglia, J., Lindborg, S. R., Alaka, K., Meehan, K., & Wright, P. (2003). Calming versus sedative effects of intramuscular olanzapine in agitated patients. The American Journal of Emergency Medicine, 21, 192–198.10.1016/S0735-6757(02)42249-8
   PubMed Web of Science ®Google Scholar
• Belgamwar, R. B., & Fenton, M. (1996). Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. In Cochrane database of systematic reviews. Hoboken, NJ: Wiley.
   Google Scholar
• Danish Ministry of Health. (2014, June 12). Nyt partnerskab skal halvere brugen af bælter i psykiatrien [New partnership should halve use of belts in psychiatry]. Retrieved from http://www.sum.dk/Aktuelt/Nyheder/Psykiatri/2014/Juni/Nyt-partnerskab-skal-halvere-brugen-af-baelter-i-psykiatrien.aspx
   Google Scholar
• Dibonaventura, M., Gabriel, S., Dupclay, L., Gupta, S., & Kim, E. (2012). A patient perspective of the impact of medication side effects on adherence: Results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry, 12, 20. doi:10.1186/1471-244X-12-20
   PubMed Web of Science ®Google Scholar
• Ekman, A., Dickman, P. W., Klint, A., Weiderpass, E., & Litton, J.-E. (2006). Feasibility of using web-based questionnaires in large population-based epidemiological studies. European Journal of Epidemiology, 21, 103–111. doi:10.1007/s10654-005-6030-4
   PubMed Web of Science ®Google Scholar
• EMA. (2014). Summary of product characteristics Adasuve. Retrieved from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002400/WC500139409.pdf
   Google Scholar
• Hankin, C. S., Bronstone, A., & Koran, L. M. (2011). Agitation in the inpatient psychiatric setting: A review of clinical presentation, burden, and treatment. Journal of Psychiatric Practice, 17, 170–185. doi:10.1097/01.pra.0000398410.21374.7d
   PubMed Web of Science ®Google Scholar
• Hsu, W.-Y., Huang, S.-S., Lee, B.-S., & Chiu, N.-Y. (2010). Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. Journal of Clinical Psychopharmacology, 30, 230–234. doi:10.1097/JCP.0b013e3181db8715
   PubMed Web of Science ®Google Scholar
• Jørgensen, T. R., Emborg, C., Dahlen, K., Bøgelund, M., & Carlborg, A. (2016). The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries. BMC Psychiatry, 16, 244. doi:10.1186/s12888-016-0930-6
   PubMed Web of Science ®Google Scholar
• Karagianis, J. L., Dawe, I. C., Thakur, A., Bégin, S., Raskin, J., & Roychowdhury, S. M. (2001). Rapid tranquilization with olanzapine in acute psychosis: A case series. The Journal of Clinical Psychiatry, 62, 12–16.
   PubMed Web of Science ®Google Scholar
• Komossa, K., Rummel-Kluge, C., Hunger, H., Schmid, F., Schwarz, S., Duggan, L., … Leucht, S. (1996). Olanzapine versus other atypical antipsychotics for schizophrenia. In Cochrane Database of Systematic Reviews. Wiley. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006654.pub2/abstract
   Google Scholar
• Kwentus, J., Riesenberg, R. A., Marandi, M., Manning, R. A., Allen, M. H., Fishman, R. S., … Cassella, J. V. (2012). Rapid acute treatment of agitation in patients with bipolar I disorder: A multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disorders, 14, 31–40. doi:10.1111/j.1399-5618.2011.00975.x
   PubMed Web of Science ®Google Scholar
• Lesem, M. D., Tran-Johnson, T. K., Riesenberg, R. A., Feifel, D., Allen, M. H., Fishman, R., … Cassella, J. V. (2011). Rapid acute treatment of agitation in individuals with schizophrenia: Multicentre, randomised, placebo-controlled study of inhaled loxapine. The British Journal of Psychiatry, 198, 51–58. doi:10.1192/bjp.bp.110.081513
   PubMed Web of Science ®Google Scholar
• Lund, E., & Gram, I. T. (1998). Response rate according to title and length of questionnaire. Scandinavian Journal of Social Medicine, 26, 154–160.
   PubMedGoogle Scholar
• Moran, P., Borschmann, R., Flach, C., Barrett, B., Byford, S., Hogg, J., … Thornicroft, G. (2010). The effectiveness of joint crisis plans for people with borderline personality disorder: Protocol for an exploratory randomised controlled trial. Trials, 11, 18. doi:10.1186/1745-6215-11-18
   PubMed Web of Science ®Google Scholar
• Mühlbacher, A. C., & Juhnke, C. (2013). Patient preferences versus physicians’ judgement: Does it make a difference in healthcare decision making? Applied Health Economics and Health Policy, 11, 163–180. doi:10.1007/s40258-013-0023-3
   PubMedGoogle Scholar
• Østergaard, M. L. D., Nordentoft, M., & Hjorthøj, C. (2017). Associations between substance use disorders and suicide or suicide attempts in people with mental illness: A Danish nation-wide, prospective, register-based study of patients diagnosed with Schizophrenia, bipolar disorder, unipolar depression or personality disorder. Addiction (Abingdon, England). Retrieved from https://doi.org/10.1111/add.13788
   PubMed Web of Science ®Google Scholar
• Swanson, J. W., Swartz, M. S., Elbogen, E. B., Van Dorn, R. A., Ferron, J., Wagner, H. R., … Kim, M. (2006). Facilitated psychiatric advance directives: A randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. The American Journal of Psychiatry, 163, 1943–1951. doi:10.1176/ajp.2006.163.11.1943
   PubMed Web of Science ®Google Scholar
• Swedish Association of Local Authorities and Regions. (2015, April 7). Bättre vård mindre tvång [Better care less compulsion]. Retrieved from http://skl.se/halsasjukvard/psykiskhalsa/battrevardmindretvang.469.html
   Google Scholar
• van Gelder, M. M. H. J., Bretveld, R. W., & Roeleveld, N. (2010). Web-based questionnaires: The future in epidemiology? American Journal of Epidemiology, 172, 1292–1298. doi:10.1093/aje/kwq291
   PubMed Web of Science ®Google Scholar